MyGov Portal
SearchFunction
Privacy Policy
feedbackform
PDPA
Broadcast
Pengenalan Kami
Berita
Soalan Lazim
Pekeliling
Hubungi Kami
Multilang
Sitemap
W3C Disability Accessibility
Number of Online Services
Freedom of Information
Online E-Participation
image
Tetapan Semula Menukar kontras kepada cerahMenukar kontras kepada asalMenukar kontras kepada gelapKecilkan size fontKembalikan saiz font kepada asalMemperbesarkan saiz font
    T
    T
    T
    T
    T
    T

bm en

Print
Tajuk Update On Avian Influenza A (H7N9) In China 30 April 2013
Penerangan

 

UPDATE ON

AVIAN INFLUENZA A (H7N9) IN CHINA

 30 APRIL 2013

 

 

Affected places:

 

Eight (8) Provinces: Anhui, Fujian, Henan, Hunan, Jiangsu, Jiangxi, Shandong and Zhejiang

Two (2) Municipalities: Beijing and Shanghai.

 

Number of cases:

 

To date, there are a total of 126 laboratory confirmed human cases with avian influenza A (H7N9) virus including 24 fatalities in China reported from eight (8) Provinces: Anhui 4 (1), Fujian 2 (0), Henan 4 (0), Hunan 2 (0), Jiangsu 26 (5), Jiangxi 4 (0), Shandong 2 (0) and Zhejiang 46 (6) and two (2) Municipalities: Beijing 1 (0) and Shanghai 34 (12), and 1 (0) Taiwan case. Currently, 78 patients are hospitalized and 24 have been discharged.

 

WHO does not advise special screening at points of entry with regard to this event, nor does it recommend that any travel or trade restrictions be applied.

 

Symptoms:

 

Symptoms include fever, cough, and shortness of breath. Infection with avian influenza A(H7N9) virus has resulted in severe respiratory illness.

 

Source and Mode of Transmission Avian Influenza A (H7N9):

 

Both the source of infection and the mode of transmission are uncertain. The Chinese health authorities are still investigating and heightened disease surveillance. So far, there is no evidence of ongoing human-to-human transmission.

 

Vaccine for Avian Influenza A (H7N9) virus:

 

No vaccine for the prevention of avian influenza A (H7N9) virus infections is currently available. The virus H7N9 is susceptible to

Neuraminidase Inhibitors (OSELTAMIVIR & ZANAMIVIR).

 

Travel advice to China and Taiwan:

 

There is no recommendation against travel to China and Taiwan at this time by WHO.

 

 

BAHAGIAN KAWALAN PENYAKIT

KEMENTERIAN KESIHATAN MALAYSIA

30 April 2013

Ditambah pada 29-04-2013 04:00:00